TerrAscend (OTCMKTS:TRSSF) Receives New Coverage from Analysts at Canaccord Genuity Group

Canaccord Genuity Group initiated coverage on shares of TerrAscend (OTCMKTS:TRSSFGet Rating) in a research note published on Monday morning, The Fly reports. The firm issued a buy rating and a C$4.25 target price on the stock.

A number of other brokerages have also weighed in on TRSSF. Stifel Nicolaus cut their target price on shares of TerrAscend from C$6.00 to C$5.50 in a research note on Friday, August 12th. Craig Hallum lowered shares of TerrAscend from a buy rating to a hold rating and cut their target price for the company from $7.50 to $2.00 in a research note on Friday, August 12th. Cantor Fitzgerald lowered shares of TerrAscend from an overweight rating to a neutral rating in a research note on Friday, August 12th. Cowen dropped their price objective on shares of TerrAscend from $9.00 to $4.50 in a research note on Monday, August 15th. Finally, Seaport Res Ptn reissued a buy rating on shares of TerrAscend in a research note on Friday, July 22nd. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of Moderate Buy and an average target price of $4.53.

TerrAscend Trading Down 2.0 %

TRSSF stock opened at $1.75 on Monday. The firm’s 50-day moving average price is $2.19 and its two-hundred day moving average price is $3.65. TerrAscend has a 12-month low of $1.62 and a 12-month high of $7.77. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.59 and a current ratio of 0.98.

TerrAscend (OTCMKTS:TRSSFGet Rating) last released its quarterly earnings data on Thursday, August 11th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.09). The business had revenue of $64.80 million for the quarter, compared to analysts’ expectations of $75.38 million. As a group, analysts expect that TerrAscend will post -0.17 EPS for the current year.

TerrAscend Company Profile

(Get Rating)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania.

Featured Stories

The Fly logo

Analyst Recommendations for TerrAscend (OTCMKTS:TRSSF)

Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.